HYDRAFIL-D

This pivotal study is designed to evaluate the safety and effectiveness of the ReGelTec HYDRAFIL System in subjects with axial chronic low back pain (CLBP) due to degenerative disc disease (DDD) who continue to have severe back pain and dysfunction after at least six (6) months of conservative care. 

• Principal Investigator- J. Scott Bainbridge, MD 
• Sub-Investigators- Drew Trainor, DO, Susan Estes, NP-C, and Michelle Hogue, FNP-BC 
• Study Details | HYDRAFIL-D: HYDRogel Augmentation for Intervertebral Lumbar Discs | ClinicalTrials.gov 
• ReGelTec HYDRAFIL-D for Low Back Pain Study Brochure PDF